← Open Payments lookup

LAURA CASTILLO: Open Payments

NPI 1992464432 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,272 in 121 payments from 40 companies in 2025. Trend: 2023 $474 · 2024 $1,747 · 2025 $3,272

Food & beverage: $3,008Education: $264
CompanyPaymentsAmount
ABBVIE INC.9$307
Merck Sharp & Dohme LLC12$258
Janssen Biotech, Inc.11$220
PFIZER INC.8$174
Daiichi Sankyo Inc.7$166
GlaxoSmithKline, LLC.7$161
TAIHO ONCOLOGY, INC.3$156
Eisai Inc.4$120
Astellas Pharma US Inc3$116
PharmaEssentia USA Corporation5$108

Products named: KEYTRUDA, VENCLEXTA, RYBREVANT, LONSURF, OJJAARA, Lenvima, BESREMI, VERZENIO.

Industry payments across TX — which companies pay providers there.